Related Experiment Video
Updated: Jul 24, 2025
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
Ameliorative Effect of Malvidin on Spleen Injury in LPS-Induced Sepsis
Jinfeng Shi1, Yan Wang2, Xiao Zhang1
1Jiangsu Key Laboratory of Marine Bioresources and Environment, Co-Innovation Center of Jiangsu Marine Bio-industry Technology, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang, 222005, China.
Abstract:
Sepsis, one of the most destructive diseases in the world, is a syndrome of systemic inflammatory response caused by the invasion of pathogenic microorganisms such as bacteria into the body. Malvidin is one of the most widespread anthocyanins, and its significant antioxidant and anti-inflammatory activities have been widely reported. However, the effect of Malvidin on sepsis and related complications is still unclear. The present study aimed to determine the mechanisms of Malvidin's potential protection from lipopolysaccharide (LPS)-induced spleen injury model of sepsis. In the LPS-induced mouse spleen injury model of sepsis, pretreatment with Malvidin was performed to assess morphological damage in spleen tissue and to detect the expression of mRNA levels of serum necrosis factor α, interleukin 1β and interleukin 6, and IL-10. Apoptosis was detected using the TUNEL technique, and the levels of oxidative stress-related oxidase and antioxidant enzymes were measured by kit to assess the effect of Malvidin on inflammation and oxidative stress associated with septic spleen injury. The results of this study indicated that Malvidin was be a potentially effective drug for the treatment of sepsis.
Insights
Malvidin, an antioxidant compound, shows potential in treating sepsis. This study found it protects against lipopolysaccharide-induced spleen injury by reducing inflammation and oxidative stress.
Area of Science:
- Pharmacology
- Immunology
- Toxicology
Background:
- Sepsis is a life-threatening systemic inflammatory response to infection.
- Malvidin, a natural anthocyanin, possesses known antioxidant and anti-inflammatory properties.
- The therapeutic potential of Malvidin in sepsis remains largely unexplored.
Purpose of the Study:
- To investigate the protective mechanisms of Malvidin against lipopolysaccharide (LPS)-induced sepsis-related spleen injury.
- To evaluate Malvidin's impact on inflammation, oxidative stress, and apoptosis in a murine sepsis model.
Main Methods:
- A lipopolysaccharide (LPS)-induced mouse model of sepsis was utilized.
- Mice were pretreated with Malvidin to assess spleen morphology and inflammatory markers (TNF-α, IL-1β, IL-6, IL-10).
- Apoptosis was quantified using TUNEL assays, and oxidative stress markers were measured.
Main Results:
- Malvidin pretreatment mitigated morphological damage in spleen tissue.
- It significantly modulated the expression of key pro-inflammatory and anti-inflammatory cytokines.
- Malvidin reduced apoptosis and ameliorated oxidative stress in the septic spleen.
Conclusions:
- Malvidin demonstrates significant protective effects against LPS-induced septic spleen injury.
- Its mechanisms involve the suppression of inflammation and oxidative stress.
- Malvidin is a promising candidate for sepsis treatment.
More Related Videos
08:04A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity
Published on: June 11, 2019
07:06Two-photon Intravital Imaging of Leukocytes During the Immune Response in Lipopolysaccharide-treated Mouse Liver
Published on: February 6, 2018